Genetic Disorders: Types, Causes and What They Mean for You and Your Family

Genetic factors influence many areas of health. Some conditions are caused mainly by a change in a single gene or chromosome, while others, such as diabetes, heart disease, and some cancers, result from a combination of genetic susceptibility, lifestyle, and environmental factors. These are not the same thing, and the distinction matters for how risk is understood and managed.

Understanding the basics of genetic disorders, inheritance patterns, and when genetic testing or counselling may be useful can help patients and families make informed healthcare decisions. This article explains what genetic disorders are, how they happen, the main categories, and what they mean practically.
 

What Is a Genetic Disorder?

A genetic disorder is a health condition caused by a disease-causing change, also called a pathogenic variant, in one or more genes, or by an abnormality in the number or structure of chromosomes. The term “mutation” is commonly used, but “pathogenic variant” or “disease-causing variant” is increasingly preferred in medical practice because it is more precise.

Genes carry instructions that help the body make proteins and regulate many biological functions. When these instructions are significantly altered, they may affect growth, development, metabolism, organ function, or long-term health.

A genetic disorder is not always inherited. Some are passed down from one or both parents, while others occur for the first time in a child due to a new, or de novo, pathogenic variant, with no prior family history. Genetic disorders should also be distinguished from congenital conditions caused mainly by infections, nutritional deficiencies, medications, toxins, or other environmental exposures during pregnancy. These are not the same as inherited genetic disorders, though they can coexist.
 

How Genetic Disorders Happen

Human cells usually contain 46 chromosomes, arranged in 23 pairs. One chromosome in each pair is inherited from the mother and one from the father. Chromosomes contain DNA, and DNA contains approximately 20,000 genes that help guide the body’s development and function. Genes carry instructions for making proteins, but some also regulate other genes or produce functional RNA.

Genetic disorders can occur through several mechanisms:

• Single-gene (pathogenic) variants: A disease-causing change in one gene can disrupt an important protein or biological pathway. These are called monogenic disorders.
• Chromosomal abnormalities: A person may have an extra chromosome, a missing chromosome, or a structural change such as a deletion, duplication, inversion, or translocation.
• Multifactorial inheritance: Many common conditions arise from the combined effect of multiple genetic variants and environmental or lifestyle factors. No single gene is responsible.
• Mitochondrial or nuclear gene changes affecting energy production: Some disorders affect mitochondria, the energy-producing structures in cells. These may be caused by changes in mitochondrial DNA or in nuclear genes that control mitochondrial function. Not all mitochondrial disorders follow maternal inheritance.
• Mosaicism: In some people, a pathogenic variant is present in only some cells of the body, which can affect disease severity and recurrence risk. Mosaicism can arise after fertilisation during early cell division.
   

Types of Genetic Disorders

Single-Gene (Monogenic) Disorders

Single-gene disorders are caused by a pathogenic variant in one gene. Many follow recognisable inheritance patterns, such as autosomal dominant, autosomal recessive, or X-linked inheritance. This can make family risk easier to estimate, although genetic counselling is still important because severity, age of onset, penetrance, and test interpretation can vary.
 

Autosomal Dominant Disorders

In autosomal dominant conditions, one disease-causing copy of a gene can be enough to cause the condition. If a parent has an autosomal dominant condition, each pregnancy has a 50% chance of inheriting the pathogenic variant.
 

Examples include:

• Huntington’s disease: A progressive neurological condition that can cause involuntary movements, cognitive decline, and psychiatric symptoms. Symptoms usually begin in adulthood. Most people with a full disease-causing CAG expansion develop symptoms, but age of onset can vary, and reduced penetrance alleles exist. The statement that everyone who inherits the variant will inevitably develop the disease is an oversimplification.
• Marfan syndrome: A connective tissue disorder that may cause tall stature, long limbs, flexible joints, eye problems, and potentially serious enlargement or weakening of the aorta, which requires regular cardiac monitoring and can be life-threatening if undetected.
• Familial hypercholesterolaemia: Causes very high LDL cholesterol from birth and significantly increases the risk of premature heart disease. Early diagnosis is important because effective treatment, including statins and other lipid-lowering therapies, can substantially reduce cardiovascular risk.
• Neurofibromatosis type 1: Causes skin changes, benign nerve tumours, and sometimes bone, eye, or learning-related problems. Severity can vary widely, even within the same family.

Some autosomal dominant conditions show variable expressivity, meaning affected people in the same family may have different symptoms or severity.
 

Autosomal Recessive Disorders

In autosomal recessive conditions, a person usually needs to inherit two disease-causing copies of a gene, one from each parent, to be affected. A person with only one copy is called a carrier. Carriers are usually healthy but can pass the pathogenic variant to their children. If both parents are carriers, each pregnancy has a 25% chance of an affected child, a 50% chance of a carrier, and a 25% chance of inheriting neither variant.
 

Examples include:

• Sickle cell disease: Red blood cells become rigid and sickle-shaped, causing anaemia, pain crises, infections, stroke risk, and organ damage. In India, it is especially important in several tribal and central/eastern populations, though it can occur in other communities as well.
• Cystic fibrosis: Causes thick mucus affecting the lungs, pancreas, digestive tract, and other organs. More common in people of European ancestry but occurs across populations.
• Phenylketonuria (PKU): Phenylalanine builds up and can cause intellectual disability if untreated. Early detection through newborn screening, where available, allows dietary treatment. Newborn screening is not yet universal in India, so access varies by state and healthcare setting.
• Thalassaemia: A group of inherited haemoglobin disorders. Beta-thalassaemia major (transfusion-dependent thalassaemia) can require lifelong transfusions. Allogeneic bone marrow transplantation is curative for eligible patients with a matched donor. Gene therapy (betibeglogene autotemcel) is now approved in some countries for eligible patients. Carrier screening before or early in pregnancy is important in high-prevalence communities.
• Congenital adrenal hyperplasia (CAH): A group of adrenal hormone disorders that may affect salt balance, growth, puberty, and genital development.
• Wilson’s disease: Causes copper accumulation in the liver, brain, and other organs. Early diagnosis and treatment can prevent serious complications.
• Spinal muscular atrophy (SMA): Affects motor nerve cells and causes progressive muscle weakness. Early diagnosis is critically important because disease-modifying therapies, including nusinersen, onasemnogene abeparvovec (a gene therapy), and risdiplam, have transformed outcomes for many patients when treatment begins early.
   

X-Linked Disorders

X-linked disorders are caused by disease-causing variants in genes on the X chromosome. Males have one X and one Y chromosome, so a single disease-causing variant on the X chromosome can cause disease. Females have two X chromosomes and may be carriers, but some females can have significant symptoms because of X-chromosome inactivation patterns or other genetic factors. Female carriers should not be assumed to be unaffected.
 

Examples include:

• Haemophilia A and B: Clotting disorders that can cause prolonged or spontaneous bleeding. They mainly affect males, but female carriers may also have low clotting factor levels and clinically significant bleeding symptoms, and should be assessed accordingly.
• Duchenne muscular dystrophy (DMD): Causes progressive muscle weakness beginning in early childhood. It mainly affects boys. Rare affected females can occur due to skewed X-inactivation or other mechanisms.
• Fragile X syndrome: Caused by expansion of a CGG repeat in the FMR1 gene. It is a common inherited cause of intellectual disability and developmental delay. Males are often more severely affected than females, though females with the full mutation can also have learning and emotional difficulties.

Some X-linked conditions are dominant, where one altered copy of the gene on a single X chromosome is enough to cause disease in both males and females, though severity may differ.
 

Chromosomal Disorders

Chromosomal disorders occur when there is an abnormal number or structure of chromosomes. These changes may happen during formation of the egg or sperm, at fertilisation, or during early cell division after fertilisation. Some people have mosaicism, where only some cells carry the chromosomal change, which can affect severity.

Diagnosis may involve tests such as karyotyping, chromosomal microarray, fluorescence in situ hybridisation (FISH), or other specialised genetic tests, depending on the suspected condition.
 

Numerical Abnormalities

Numerical chromosomal abnormalities involve having an extra or missing chromosome.

• Down syndrome (Trisomy 21): Caused by an extra copy of chromosome 21. It may cause developmental delay, characteristic physical features, and increased risk of heart defects, thyroid disease, hearing or vision problems, and other health issues. Outcomes vary widely, and early medical, developmental, and educational support is important. The risk increases with maternal age, though the majority of affected pregnancies still occur in younger mothers due to higher overall birth rates in younger women.
• Edwards syndrome (Trisomy 18): Caused by an extra chromosome 18. Associated with severe developmental and structural abnormalities. Many affected pregnancies do not survive to term, and infant mortality is high in those born alive.
• Patau syndrome (Trisomy 13): Caused by an extra chromosome 13, associated with severe developmental and organ abnormalities.
• Turner syndrome (45, X): Affects females who have one X chromosome missing or partly missing, sometimes in mosaic form. Can cause short stature, ovarian insufficiency, infertility, and heart or kidney abnormalities.
• Klinefelter syndrome (47, XXY): Affects males with an extra X chromosome. It may cause reduced testosterone, infertility, learning difficulties, or may be diagnosed late because symptoms can be mild. Many men are not diagnosed until they seek help for infertility.
   

Structural Abnormalities

Structural chromosomal abnormalities include deletions, duplications, inversions, and translocations. These may disrupt genes or alter gene dosage.

• DiGeorge syndrome / 22q11.2 deletion syndrome: May cause heart defects, immune problems, low calcium, palate abnormalities, learning difficulties, and other features.
• Williams syndrome: Caused by a deletion on chromosome 7. It may cause developmental delay, characteristic behavioural and cognitive features, and cardiovascular problems.
• Prader-Willi and Angelman syndromes: Both involve abnormalities in a region of chromosome 15, but the clinical features differ depending on whether the affected genetic material comes from the mother or father. This is due to genomic imprinting.
• Balanced translocations: A person with a balanced translocation may have no symptoms if no genetic material is lost or gained, but there may be an increased risk of miscarriage, infertility, or having a child with an unbalanced chromosomal condition. This is an important consideration in couples with recurrent pregnancy loss.
   

Multifactorial Conditions with Genetic Contribution

Many common conditions are multifactorial, meaning they arise from a combination of genetic susceptibility, lifestyle, environment, ageing, and sometimes chance. These are not genetic disorders in the same sense as single-gene or chromosomal conditions. They usually do not follow simple inheritance patterns, and having a family history raises risk but does not make the condition inevitable.

Common multifactorial conditions include:

• Type 2 diabetes
• Coronary artery disease
• Hypertension
• Some cancers (most cancers are multifactorial or somatic; a minority are due to inherited high-risk gene variants)
• Asthma and allergies
• Cleft lip and palate
• Neural tube defects such as spina bifida
• Some psychiatric conditions, including schizophrenia and bipolar disorder

For many of these conditions, risk can be meaningfully reduced through appropriate screening, healthy weight, physical activity, avoiding tobacco, limiting alcohol, good control of blood pressure and cholesterol, and timely medical care. For example, a person with a strong family history of type 2 diabetes has higher lifetime risk, but healthy lifestyle measures and regular screening can delay onset or reduce the risk of complications.
 

Mitochondrial Disorders

Mitochondria are the energy-producing structures inside cells. Mitochondrial disorders often affect organs with high energy demands, such as the brain, muscles, heart, eyes, liver, and kidneys.

Some mitochondrial disorders are caused by changes in mitochondrial DNA, which is usually inherited from the mother. Others are caused by changes in nuclear genes that control mitochondrial function, and these may follow autosomal recessive, autosomal dominant, or X-linked inheritance patterns. It is incorrect to assume all mitochondrial disorders follow maternal inheritance.

Even when a mitochondrial DNA pathogenic variant is inherited maternally, severity can vary widely among children because the proportion of affected mitochondrial DNA can differ between tissues and between family members. This is called heteroplasmy. An affected mother does not necessarily pass on the same level of disease to all her children. Genetic counselling is important for accurate risk assessment.

Examples include Leber hereditary optic neuropathy, MELAS syndrome (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes), and MERRF syndrome.
 

The Indian Context: Why This Matters Here Specifically

India has a highly diverse genetic landscape. Some inherited conditions are more common in specific regions or communities, making awareness, screening, and counselling especially important.

• Haemoglobin disorders: India carries one of the largest global burdens of haemoglobin disorders. Sickle cell disease is highly prevalent in tribal populations across Central and Eastern India. Thalassaemia carrier rates are high in Gujarat, Maharashtra, West Bengal, Tamil Nadu, and Punjab. Carrier screening, premarital or preconception counselling, prenatal diagnosis where appropriate, and newborn screening in high-prevalence areas can reduce complications and support informed family planning. The National Sickle Cell Anaemia Elimination Mission (2023–2047) reflects India’s commitment to reducing sickle cell disease burden through population screening and intervention.
• Consanguineous marriages: Marriage between biological relatives is practised in some communities in India. This can increase the chance that both partners carry the same autosomal recessive pathogenic variant. Couples in such situations may benefit from preconception genetic counselling. ACOG recommends offering genetic counselling to consanguineous couples because of the increased risk of recessive conditions. This guidance is offered in the context of informed, supportive care and is not a judgment on cultural practices.
• Population-specific risks: Some communities may have higher rates of specific genetic variants because of historical founder effects or endogamy. Risk should be assessed using family history, community background, and appropriate testing rather than assumptions about specific communities.
• Newborn screening: In India, newborn screening is available in some states and many private hospitals but is not yet universal. Early screening can help detect treatable conditions before symptoms develop.
• Genetic counselling access: Genetic counselling services are growing but remain concentrated in larger cities and tertiary centres. Improving awareness and access is important for families with suspected inherited disorders.
   

Genetic Testing: When Is It Relevant?

Genetic testing is useful when the result can guide diagnosis, treatment, screening, or family planning. It is not needed for everyone.

• Carrier testing: Helps identify whether a person carries a pathogenic variant for an autosomal recessive or X-linked condition, especially before pregnancy or early in pregnancy.
• Prenatal screening and diagnostic testing: Screening tests, such as ultrasound, biochemical screening, or non-invasive prenatal testing (NIPT), estimate risk for chromosomal abnormalities. They are not diagnostic. Diagnostic tests, such as chorionic villus sampling (CVS) or amniocentesis, can confirm certain chromosomal or single-gene conditions but are invasive and require specialist counselling before the procedure.
• Newborn screening: Tests babies soon after birth for selected treatable conditions so that early treatment can prevent harm.
• Diagnostic testing: When symptoms, examination findings, or family history suggest a genetic condition.
• Predictive and presymptomatic testing: For adult-onset conditions such as Huntington’s disease or hereditary cancer syndromes. These tests require careful counselling because results may have significant emotional and family implications.
• Pharmacogenomic testing: In selected situations, genetic testing can help predict how a person may respond to certain medicines or doses. This is not routinely appropriate for all medications.

Before genetic testing, patients should understand what the test can and cannot answer, the possibility of uncertain or incidental findings, whether results may affect other family members, and the need for expert interpretation. A negative result does not rule out every genetic condition, only those tested for.
 

Genetic Counselling: What It Is and Who It’s For

Genetic counselling is a structured process that helps individuals and families understand genetic risk, testing options, and the implications of a diagnosis. It may be provided by a genetic counsellor, clinical geneticist, or other trained specialist depending on local availability.

Genetic counselling can help with:

• Reviewing personal and family history
• Estimating the chance of a genetic condition
• Deciding whether genetic testing is appropriate
• Understanding test results, including uncertain or borderline results
• Discussing reproductive options and informed consent
• Planning screening or preventive care
• Identifying whether relatives may also need counselling or testing (cascade testing)
• Navigating the emotional and practical implications of a genetic diagnosis

Genetic counselling is relevant for the same situations listed in the “When to Seek Genetic Advice” section below.

Genetic counselling is not about telling people what to do. It is about giving accurate information, helping people understand their options, and supporting them in making decisions that align with their own values.
 

Myths About Genetic Disorders

Myth: Genetic disorders are always rare.

What the evidence shows: Some single-gene and chromosomal disorders are rare, but genetic factors also contribute to many common conditions such as type 2 diabetes, heart disease, hypertension, and some cancers. These common multifactorial conditions are not genetic disorders in the same sense as single-gene or chromosomal conditions, but genetic susceptibility plays a meaningful role.
 

Myth: If no one in my family has a condition, I cannot carry a pathogenic variant.

What the evidence shows: For autosomal recessive conditions, carriers are usually healthy and unaware they carry the variant. Two carrier parents may have no family history and still have an affected child. This is particularly relevant for thalassaemia and sickle cell disease in India.
 

Myth: A genetic diagnosis means nothing can be done.

What the evidence shows: Many genetic conditions can be treated, monitored, or managed. Early diagnosis may prevent complications in some conditions. PKU and some other newborn-screened metabolic conditions can be managed to prevent significant harm. Even where there is no cure, supportive care, surveillance, rehabilitation, medicines, or disease-modifying treatments can improve outcomes. Not all genetic conditions are as directly treatable as PKU, so generalising across conditions should be avoided.
 

Myth: Genetic testing always gives a yes-or-no answer.

What the evidence shows: Sometimes it does, but results can include probabilities, risk estimates, or variants of uncertain significance. These need expert interpretation. The right test depends on the clinical context and what question is being asked.
 

Myth: A negative genetic test means there is no risk.

What the evidence shows: A negative result reduces risk only for the specific condition or variants tested. It does not rule out every genetic condition. Interpreting a negative result requires understanding what the test was designed to detect.
 

Myth: Genetic disorders are only relevant when planning a pregnancy.

What the evidence shows: Genetic information can guide cancer screening, heart disease prevention, medication choices, and diagnosis of unexplained symptoms at any age.
 

When to Seek Genetic Advice

Talk to your doctor about a referral to a genetic specialist or counsellor if:

• A close relative has a known genetic condition
• You and your partner are related by blood (consanguineous relationship)
• You or your partner are from a community with known high carrier rates for a specific condition (such as thalassaemia in Gujarat or sickle cell disease in tribal communities)
• You have had repeated miscarriages, a stillbirth, or a child with a birth defect or developmental disability
• A child has intellectual disability, unusual physical features, unexplained seizures, muscle weakness, or a condition that doctors have not been able to explain
• A newborn has unexplained severe illness, very low blood sugar, seizures, poor feeding, metabolic acidosis, or metabolic crisis
• A prenatal screening test has come back with an abnormal or high-risk result
• You or a close relative has been diagnosed with cancer at a young age, or multiple family members have had the same type of cancer
• There is a family history of sudden unexplained death, cardiomyopathy, serious arrhythmia, or inherited heart disease at a young age
• You have received a genetic test result that you do not fully understand
• You have a personal or family history of a condition that might have a hereditary component and you want to understand your risk
   

Summary

Genetic disorders range from conditions caused by a single gene pathogenic variant to chromosomal disorders and mitochondrial conditions. Genetic factors also contribute to many common multifactorial conditions, where lifestyle, environment, and ageing interact with inherited susceptibility. These two categories are distinct and should not be conflated.

The main categories are:

• Single-gene disorders, which follow autosomal dominant, autosomal recessive, or X-linked inheritance patterns
• Chromosomal disorders, caused by extra, missing, or structurally altered chromosomes
• Multifactorial conditions with genetic contribution, common conditions where multiple genes interact with lifestyle and environmental factors
• Mitochondrial disorders, affecting cellular energy production, with inheritance depending on whether mitochondrial DNA or nuclear DNA is involved

In India, thalassaemia, sickle cell disease, consanguinity-related recessive disorders, and unequal access to newborn screening make genetic awareness especially important.

A genetic diagnosis should be seen as useful medical information. Testing and counselling should always be guided by personal and family history and clinical context. It can support earlier diagnosis, better surveillance, informed family planning, and, in some cases, targeted treatment.
 

Frequently Asked Questions

1. Are all genetic disorders present from birth?

No. Some genetic conditions are present or detectable at birth, while others appear in childhood, adulthood, or later in life. For example, Huntington’s disease usually causes symptoms in adulthood, although the genetic change is present from conception. Hereditary cancer gene variants, such as BRCA1 or BRCA2, increase cancer risk but do not mean that cancer is certain. The age of onset varies widely by condition.
 

2. Can genetic disorders be cured?

Some genetic conditions can be effectively treated or controlled, especially when detected early. For example, PKU can be managed with a special diet to prevent intellectual disability. Some newborn-screened metabolic conditions can be treated before serious harm occurs. Gene-based and disease-modifying therapies are now available for selected conditions, such as some forms of spinal muscular atrophy, inherited retinal disease, and haemophilia, but they are not available or appropriate for every genetic disorder. For most conditions, treatment focuses on preventing complications and supporting quality of life.
 

3. If one of my children has a genetic disorder, what is the risk for future children?

The risk depends on the exact diagnosis and inheritance pattern. For some autosomal recessive conditions, each pregnancy has a 25% chance of being affected. For autosomal dominant conditions caused by a new (de novo) variant in the child, recurrence risk may be low, but not always zero, because of rare parental germline mosaicism, where the variant is present in some of a parent’s egg or sperm cells. A genetic counsellor can estimate recurrence risk using the child’s diagnosis and, where needed, parental test results.
 

4. Is genetic testing available in India?

Yes. Genetic testing is available through specialised laboratories, tertiary hospitals, and some government-supported programmes. Availability depends on the condition, location, and type of test required. Testing for haemoglobin disorders such as thalassaemia and sickle cell disease is more widely available in high-prevalence regions. Advanced tests such as gene panels, whole exome sequencing, or whole genome sequencing are generally available through specialised centres. Access remains unequal between urban and rural areas, and costs vary. Genetic counselling is recommended before and after testing.
 

5. What is the difference between genetic testing and genomic testing?

Genetic testing often refers to testing for a specific condition, gene, or known family variant. Genomic testing looks at many genes, the exome, or the whole genome and is useful when the diagnosis is unclear or when several genes could be involved. More extensive testing is not always better. The right test depends on the clinical question, symptoms, family history, and how the result will be used. Both require careful interpretation and should be ordered with medical guidance.
 

6. Can lifestyle choices affect a genetic condition?

Lifestyle cannot remove an inherited pathogenic variant, but it can influence health outcomes. In familial hypercholesterolaemia, LDL cholesterol is high because of the genetic condition, but diet, exercise, avoiding smoking, and cholesterol-lowering medicines are still important to reduce cardiovascular risk. For multifactorial conditions such as type 2 diabetes, heart disease, and hypertension, lifestyle can strongly influence whether genetic susceptibility turns into disease and how early complications develop.
 

7. What is preimplantation genetic testing?

Preimplantation genetic testing (PGT) is performed during IVF. Embryos are tested for a specific genetic condition or chromosomal abnormality before transfer to the uterus. It may help couples at risk of passing on a serious genetic condition identify embryos that do not carry the tested disorder. PGT has limitations, requires IVF, and specialist counselling is essential. In some cases, confirmatory prenatal testing may still be recommended.

Current terminology includes PGT-M for monogenic (single-gene) conditions, PGT-A for chromosomal aneuploidy screening, and PGT-SR for structural chromosomal rearrangements. The older term “preimplantation genetic diagnosis” (PGD) refers to the same concept.
 

8. Should I get genetic testing if I have no symptoms and no known family history?

For most people with no symptoms and no relevant family history, broad genetic testing is not routinely required. Testing may be useful in specific situations, such as preconception carrier screening, belonging to a community with a high carrier rate for a specific condition, abnormal screening results, or a personal history of cancer or heart disease that suggests a hereditary syndrome. Direct-to-consumer genetic tests are not a substitute for medical evaluation. Discussing the need for testing with a doctor or genetic counsellor helps ensure the right test is chosen and interpreted correctly.